S. Salvin

1.4k citations

20 papers · 917 indexed · h-index 13

Rheumatology top 2%
- Systemic Lupus Erythematosus Research 9
- Rheumatoid Arthritis Research and Therapies 4
Periodontics top 5%
- Oral Health Pathology and Treatment 5
Physiology top 5%
- Salivary Gland Disorders and Functions 13
Immunology
Surgery top 10%
- Salivary Gland Tumors Diagnosis and Treatment 10
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Genetics
- Diabetes and associated disorders 1
Complementary and Manual Therapy
- Temporomandibular Joint Disorders 1

Co-authors: Luca Quartuccio Salvatore De Vita Martina Fabris Miriam Isola Gaëtane Nocturne Raphaèle Séror Philippe Ravaud Xavier Mariette
Cited by: Rheumatology Periodontics Physiology
Journals: Annals of the Rheumatic Diseases (5 papers)Lara D. Veeken (5 papers)Journal of Autoimmunity (1 paper)
Partner nations: Italy United States France

In The Last Decade

S. Salvin

19 papers receiving 905 citations

Peers

Countries citing papers authored by S. Salvin

Since Specialization

Citations

This map shows the geographic impact of S. Salvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Salvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Salvin more than expected).

Fields of papers citing papers by S. Salvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Salvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Salvin. The network helps show where S. Salvin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Salvin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Salvin Line = papers co-authored together S. Salvin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism Italian Journal of Public Health ·Luca Quartuccio,S. Salvin,Martina Fabris,Maurizio Benucci,Raffaele Pellerito,G Mehrle,Paola Masolini,Marco A. Cimmino,Maria Grazia Troncon,Giovanni Maria Guarrera,Salvatore De Vita	2024	0
2	Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. PubMed ·Alen Zabotti,S. Salvin,Luca Quartuccio,De Vita S	2016	70
3	Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study. PubMed ·Luca Quartuccio,S. Salvin,L. Corazza,Saviana Gandolfo,Martina Fabris,Salvatore De Vita	2016	23
4	Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study Lara D. Veeken ·Salvatore De Vita,Luca Quartuccio,Raphaèle Séror,S. Salvin,Philippe Ravaud,Martina Fabris,Gaëtane Nocturne,Saviana Gandolfo,Miriam Isola,Xavier Mariette	2015	109
5	THU0394 Worsening of Systemic Activity and Increases of B-Cell Biomarkers in sjögren's Syndrome after Suspension of Belimumab Treatment: Long-Term Follow-Up After the End of the Beliss Study Annals of the Rheumatic Diseases ·Luca Quartuccio,S. Salvin,L. Corazza,Saviana Gandolfo,Cinzia Pistis,Martina Fabris,Salvatore De Vita	2015	1
6	THU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study Annals of the Rheumatic Diseases ·Salvatore De Vita,Luca Quartuccio,Raphaèle Séror,S. Salvin,Philippe Ravaud,Martina Fabris,Gaëtane Nocturne,Saviana Gandolfo,Miriam Isola,Xavier Mariette	2015	5
7	Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study Scandinavian Journal of Rheumatology ·Luca Quartuccio,Miriam Isola,Chiara Baldini,Roberta Priori,Elena Bartoloni,Francesco Carubbi,Giorgia Gregoraci,Saviana Gandolfo,S. Salvin,Nicoletta Luciano,Antonina Minniti,Alessia Alunno,Roberto Giacomelli,Roberto Gerli,Guido Valesini,Stefano Bombardieri,Salvatore De Vita	2014	32
8	High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. PubMed ·Martina Fabris,Riccardo Dolcetti,Elisa Pasini,Luca Quartuccio,Elena Pontarini,S. Salvin,Maurilio Ponzoni,Cathryn Anne Scott,Salvatore De Vita	2014	12
9	Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. PubMed ·Salvatore De Vita,Luca Quartuccio,S. Salvin,Sergio David Diaz Marín,Cathryn Anne Scott,Maurizio Rupolo,Martina Fabris	2014	64
10	Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study Journal of Autoimmunity ·Luca Quartuccio,Miriam Isola,Chiara Baldini,Roberta Priori,Elena Bartoloni,Francesco Carubbi,M. Maset,Giorgia Gregoraci,Vincenzo Della Mea,S. Salvin,G. De Marchi,Nicoletta Luciano,Serena Colafrancesco,Alessia Alunno,Roberto Giacomelli,Roberto Gerli,Guido Valesini,Stefano Bombardieri,Salvatore De Vita	2013	102
11	Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study Annals of the Rheumatic Diseases ·Xavier Mariette,Raphaèle Séror,Luca Quartuccio,Gabriel Baron,S. Salvin,Martina Fabris,Frédéric Desmoulins,Gaëtane Nocturne,Philippe Ravaud,Salvatore De Vita	2013	225
12	BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands Lara D. Veeken ·Luca Quartuccio,S. Salvin,Martina Fabris,M. Maset,Elena Pontarini,Miriam Isola,Salvatore De Vita	2012	116
13	THU0188 Lymphoproliferative complications in the course of primary sjægren's syndrome: Prevalence and common features in a large cohort of patients Annals of the Rheumatic Diseases ·Luca Quartuccio,Chiara Baldini,Roberta Priori,Elena Bartoloni,Francesco Carubbi,Miriam Isola,M. Maset,S. Salvin,Nicoletta Luciano,胡英军,Alessia Alunno,Alessandra Marrelli,Roberto Gerli,Guido Valesini,Stefano Bombardieri,Salvatore De Vita	2012	1
14	Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy Lara D. Veeken ·Salvatore De Vita,Luca Quartuccio,S. Salvin,L. Corazza,Alen Zabotti,Martina Fabris	2011	27
15	Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis Reumatismo ·Luca Quartuccio,S. Salvin,Marta Saracco,Stefania Lombardi,Martina Fabris,Elisa Mansutti,M. Maset,Tülay Demircan,Salvatore De Vita	2011	2
16	Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis Lara D. Veeken ·Luca Quartuccio,Martina Fabris,S. Salvin,Fabiola Atzeni,Marta Saracco,Maurizio Benucci,Marco A. Cimmino,P Morassi,Paola Masolini,R. Pellerito,Maurizio Cutolo,(unknown),Salvatore De Vita	2009	73
17	Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation International Journal of Rheumatology ·Luca Quartuccio,Martina Fabris,S. Salvin,M. Maset,G. De Marchi,Salvatore De Vita	2009	29
18	Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis Bone ·S. Salvin,Luca Quartuccio,M. Maset,Suzete C. Ferreira,Stefania Sacco,Elisa Mansutti,Salvatore De Vita	2009	3
19	Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis Lara D. Veeken ·Luca Quartuccio,Martina Fabris,S. Salvin,Miriam Isola,Franca Soldano,Edmondo Falleti,Carlo Alberto Beltrami,Vallì De Re,Salvatore De Vita	2007	12
20	Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia Annals of the Rheumatic Diseases ·Martina Fabris,Luca Quartuccio,S. Salvin,Gabriele Pozzato,Vallì De Re,Cesare Mazzaro,Clodoveo Ferri,Chiara Baldini,Salvatore De Vita	2007	11

About S. Salvin

S. Salvin is a scholar working on Periodontics, Rheumatology, Physiology, Complementary and Manual Therapy and Surgery, having authored 20 papers that have together received 917 indexed citations. Recurring topics across this work include Salivary Gland Disorders and Functions (13 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers), Systemic Lupus Erythematosus Research (9 papers), Oral Health Pathology and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Diabetes and associated disorders (1 paper) and Temporomandibular Joint Disorders (1 paper). The work is most often cited by research in Rheumatology (404 citations), Periodontics (106 citations), Physiology (587 citations), Immunology (182 citations) and Surgery (303 citations). S. Salvin has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Luca Quartuccio, Salvatore De Vita, Martina Fabris, Miriam Isola, Gaëtane Nocturne, Raphaèle Séror, Philippe Ravaud, Xavier Mariette, M. Maset and Frédéric Desmoulins. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Journal of Autoimmunity, International Journal of Rheumatology and Bone.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact